about
Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry.Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditisIntraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?Calcium handling and ventricular tachyarrhythmias.Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.Ivabradine Reduces Digitalis-induced Ventricular Arrhythmias.Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- Syndrome.Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone.Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.New formula for evaluation of the QT interval in patients with left bundle branch block.Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke.Antiarrhythmic effect of vernakalant in an experimental model of Long-QT-syndrome.Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.Incidence and management of inadvertent puncture and sheath placement in the aorta during attempted transseptal puncture.Divergent electrophysiologic profile of fluconazole and voriconazole in an experimental whole-heart model of proarrhythmia.Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience.Outcome predictors of empirical slow pathway modulation: clinical and procedural characteristics and long-term follow-up.Routine 18F-FDG PET/CT does not detect inflammation in the left atrium in patients with atrial fibrillation.Patients with atrial fibrillation complicated by coronary artery disease. Is a single value of sensitive cardiac troponin I on admission enough?The Effects of SEA0400 on Ca2+ Transient Amplitude and Proarrhythmia Depend on the Na+/Ca2+ Exchanger Expression Level in Murine Models.Increased sodium/calcium exchanger activity enhances beta-adrenergic-mediated increase in heart rate: Whole-heart study in a homozygous sodium/calcium exchanger overexpressor mouse model.Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.Ventricular arrhythmias from the mitral annulus: patient characteristics, electrophysiological findings, ablation, and prognosis.Electrophysiological profile of vernakalant in an experimental whole-heart model: the absence of proarrhythmia despite significant effect on myocardial repolarization.Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3.The ECG in cardiovascular-relevant animal models of electrophysiology.Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems.Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedarone.Applicability of a Novel Formula (Bogossian formula) for Evaluation of the QT-Interval in Heart Failure and Left Bundle Branch Block Due to Right Ventricular Pacing.Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.Right versus left parasternal electrode position in the entirely subcutaneous ICD.Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.[Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].Broad antiarrhythmic effect of mexiletine in different arrhythmia models.Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model.Visualization of local abnormal ventricular activities in scar-related ventricular tachycardia. A novel strategy.Dronedarone and digitalis: individually reduced post-repolarization refractoriness enhances life-threatening arrhythmias.
P50
Q31071874-75747E85-D2C6-459C-804B-1F28A2985DAEQ33828989-F64CA4FA-888F-4221-93CF-2080667857EFQ37090875-FDE03279-2EA0-4004-B877-EB193731A424Q38016750-3825853A-6744-4537-9520-686A6ACBFFF1Q38551020-ABE2C2F6-D0B7-4964-8809-AFF48BCED57FQ38719493-7AD03B78-DD04-4968-81CB-5FDE497607C9Q38726604-DF46D850-B9A6-4BF7-A5EC-613E5E150147Q38757022-EF08221C-9094-45B3-8FFA-6260E26C286CQ38968608-2303BC31-4583-4246-B82C-70A6B4BDF8CEQ39047609-537AB7DF-6B90-46D6-B760-D3E808182D4BQ39140996-C6A6DEF5-E76F-4387-8F53-877590E09B58Q39272355-93C7B2AE-3E9D-4E59-A683-2C6731087EEBQ39323366-54BAED5D-0C6F-4952-9889-9C2C28C47D79Q39609214-719E642F-5859-4EF7-9D0F-19B797B3DB40Q39694725-D16BC4DA-221A-44D4-8D92-0764C7DCB1E6Q39741721-CCDF31F9-FDD1-47DD-947F-8AC89A5FCC46Q39900261-DDE6E09A-2C97-4351-980E-D7075E781811Q39976447-476DBE88-534A-48C1-9F67-D7390CAF7556Q40669780-E271AC9B-4BF4-4374-B7BE-E69F6F3C9857Q40917925-A52E45DD-A608-45BB-B1B5-C8E3B1F3F718Q40961876-3D43AA21-3AA9-4EB3-9E03-AAD4938FDBC2Q41476995-D31B872B-5D78-4EE9-8D04-8092AA10B779Q42363815-0511FE50-9DE2-4ACA-8775-BF3228B8B51BQ42509616-B77CFB13-7C72-4868-AA46-AF18ADE6C679Q43952443-AB3518C4-276E-45DC-A312-80FE1BB9B39DQ44710701-9C8F24F6-3939-4CEF-AE52-C87DB35E6C5EQ45812687-E500898B-E62F-4F76-96CB-2A5A4B8E1DD1Q46311431-92BDE777-2C88-4EA7-88A6-2B52FE9C0E19Q46431784-8BA5381A-D470-4949-93A1-2B46020885C3Q47870406-21B614DE-D88B-46EB-BEAC-7A31D2982C2CQ47942378-D22B9A6E-0805-48AE-A40A-BDCC1F22B33AQ47983868-7611F30B-F8F7-41DA-B2F2-126BF87332FAQ48286908-C3164922-1057-4FAA-A335-A7C4AA630585Q48334283-E9C6679D-6AD3-421A-9959-DB332626409AQ49604689-61BE5C8D-0505-469B-83A1-294B20704337Q50051488-0C24EB20-68BF-48C5-B941-01F1C1A304A1Q50089146-6696D792-9F4B-4405-95A3-C502D819B9AFQ50926305-73564117-11A8-4F8A-BA44-BBAC1C7BCB2BQ51012283-50719F0B-1FB8-40C2-A77D-8376CA9DBC4AQ51051828-73577454-8076-49E7-8E86-1489CDA75307
P50
name
Gerrit Frommeyer
@en
type
label
Gerrit Frommeyer
@en
prefLabel
Gerrit Frommeyer
@en